CDER Closes Out 2008 With 24 Novel Approvals, But Few Are First In Class

FDA’s second-half surge in approvals made 2008 the agency’s best year for NME approval counts since 2004, but the relatively high number is generated by a slate of products with a relatively low level of innovation.